Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 314

    1.

    Blockade of tumor necrosis factor-related apoptosis-inducing ligand exacerbates type 1 diabetes in NOD mice.

    Mi QS, Ly D, Lamhamedi-Cherradi SE, Salojin KV, Zhou L, Grattan M, Meagher C, Zucker P, Chen YH, Nagle J, Taub D, Delovitch TL.

    Diabetes. 2003 Aug;52(8):1967-75.PMID: 12882912 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes.

    Lamhamedi-Cherradi SE, Zheng S, Tisch RM, Chen YH.

    Diabetes. 2003 Sep;52(9):2274-8.PMID: 12941766 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death.

    Suk K, Kim S, Kim YH, Kim KA, Chang I, Yagita H, Shong M, Lee MS.

    J Immunol. 2001 Apr 1;166(7):4481-9.PMID: 11254704 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Critical contribution of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) to apoptosis of human CD4+ T cells in HIV-1-infected hu-PBL-NOD-SCID mice.

    Miura Y, Misawa N, Maeda N, Inagaki Y, Tanaka Y, Ito M, Kayagaki N, Yamamoto N, Yagita H, Mizusawa H, Koyanagi Y.

    J Exp Med. 2001 Mar 5;193(5):651-60.PMID: 11238596 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Tumor necrosis factor-related apoptosis-inducing ligand and CD56 expression in patients with type 1 diabetes mellitus.

    Cheung SS, Metzger DL, Wang X, Huang J, Tai J, Tingle AJ, Ou D.

    Pancreas. 2005 Mar;30(2):105-14.PMID: 15714132 [PubMed - indexed for MEDLINE]Related articles

    6.

    Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells.

    Grewal IS, Grewal KD, Wong FS, Picarella DE, Janeway CA Jr, Flavell RA.

    J Exp Med. 1996 Nov 1;184(5):1963-74.PMID: 8920883 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression.

    Song K, Chen Y, Göke R, Wilmen A, Seidel C, Göke A, Hilliard B, Chen Y.

    J Exp Med. 2000 Apr 3;191(7):1095-104.PMID: 10748228 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Mechanisms of accelerated immune-mediated diabetes resulting from islet beta cell expression of a Fas ligand transgene.

    Silva DG, Petrovsky N, Socha L, Slattery R, Gatenby P, Charlton B.

    J Immunol. 2003 May 15;170(10):4996-5002.PMID: 12734343 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells.

    Lünemann JD, Waiczies S, Ehrlich S, Wendling U, Seeger B, Kamradt T, Zipp F.

    J Immunol. 2002 May 15;168(10):4881-8.PMID: 11994437 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.

    Hilliard B, Wilmen A, Seidel C, Liu TS, Göke R, Chen Y.

    J Immunol. 2001 Jan 15;166(2):1314-9.PMID: 11145715 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.

    Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H.

    J Immunol. 1999 Aug 15;163(4):1906-13.PMID: 10438925 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Tumor-infiltrating CD4+ T lymphocytes express APO2 ligand (APO2L)/TRAIL upon specific stimulation with autologous lung carcinoma cells: role of IFN-alpha on APO2L/TRAIL expression and -mediated cytotoxicity.

    Dorothée G, Vergnon I, Menez J, Echchakir H, Grunenwald D, Kubin M, Chouaib S, Mami-Chouaib F.

    J Immunol. 2002 Jul 15;169(2):809-17.PMID: 12097384 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice.

    Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL.

    J Immunol. 2001 Jul 15;167(2):1081-9.PMID: 11441119 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse.

    Stephens LA, Kay TW.

    Int Immunol. 1995 Dec;7(12):1885-95.PMID: 8746558 [PubMed - indexed for MEDLINE]Related articles

    18.

    Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice.

    Kim S, Kim HS, Chung KW, Oh SH, Yun JW, Im SH, Lee MK, Kim KW, Lee MS.

    Diabetes. 2007 Oct;56(10):2561-8. Epub 2007 Jul 9.PMID: 17620422 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    In vivo apoptosis of diabetogenic T cells in NOD mice by IFN-gamma/TNF-alpha.

    Qin HY, Chaturvedi P, Singh B.

    Int Immunol. 2004 Dec;16(12):1723-32. Epub 2004 Oct 18.PMID: 15492021 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs.

    Kayagaki N, Yamaguchi N, Nakayama M, Eto H, Okumura K, Yagita H.

    J Exp Med. 1999 May 3;189(9):1451-60.PMID: 10224285 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data